PhD in Neurodevelopment & Developmental Disruption

Rigshospitalet; Denmark; On-site; DKK 314,000 - 404,000; Full time

Job summary

PhD position in Neurodevelopment and Developmental Disruption at Copenhagen University Hospital – Rigshospitalet invites applications for a 3-year PhD. The project studies how environmental and pharmaceutical exposures during early life may influence brain development and risk of disorders such as ADHD, with collaboration across University of Copenhagen, Roskilde University, and Harvard.

The successful candidate will conduct experimental work with cell lines, iPSC, animal models, and molecular

Qualifications

• Master’s degree in life sciences (neuroscience, biology, molecular biomedicine, pharmacy, biochemistry, or medicine).
• Experience with in vitro laboratory work.
• Interest in neurodevelopment and developmental toxicology.
• Good English communication skills, oral and written.
• Experience conducting independent research projects.

Responsibilities

• Conduct experimental laboratory research with cell lines, primary cells, human iPSC, molecular imaging and molecular biology techniques.
• Participate in animal experiments including behavioural testing and MR analyses.
• Independently plan and carry out defined research projects.
• Communicate research findings at group meetings and international conferences, and through manuscripts.
• Collaborate closely with technical staff and students.
• Contribute to overall activities of the research group and project development.
• Experience with animal behavioural testing and analysis software is advantageous.

Skills

In vitro lab work

Independent research

English communication

Neurodevelopment interest

Animal research interest

Education

Master’s degree in life sciences

FELASA Function A/B/D certificate

Tools

FELASA certificate

Job description

PhD position in Neurodevelopment and Developmental Disruption at Copenhagen University Hospital – Rigshospitalet invites applications for a 3-year PhD. The project studies how environmental and pharmaceutical exposures during early life may influence brain development and risk of disorders such as ADHD, with collaboration across University of Copenhagen, Roskilde University, and Harvard.

The successful candidate will conduct experimental work with cell lines, iPSC, animal models, and molecular